Biopsy Needle Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Biopsy Needle Market size was over USD 1.38 Billion in 2026 and is likely to grow at 7% CAGR between 2027 and 2036, exceeding USD 2.71 Billion by 2036. The industry revenue for 2027 is estimated at USD 1.46 Billion.
Get more details on this report
Request Free Sample ReportBiopsy Needle Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026, supported by advanced healthcare infrastructure, minimally invasive diagnostic adoption, established pathways, and investments in hospital and diagnostic capabilities.
- Expanding healthcare infrastructure, rising diagnostic investment, hospital modernization, and greater awareness of early disease detection are supporting faster adoption across emerging markets.
Segment Momentum
- Needle based biopsy guns held 73.54% of the market in 2026 and remain the fastest-growing product segment because they deliver consistent tissue samples, improve procedural precision, enhance clinician control, and support minimally invasive diagnostics.
- The cancer/tumor application segment is projected to grow the fastest, driven by increasing emphasis on early cancer diagnosis, wider adoption of image-guided biopsy procedures, and rising demand for personalized treatment planning.
Market Expansion Drivers
- Rising global cancer incidence driving demand for minimally invasive biopsy procedures
- Technological advancements improving precision and safety of biopsy needle systems
- Expanding breast cancer awareness and screening programs boosting diagnostic biopsy adoption
Leading Market Participants
- Prominent players in the biopsy needle market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Becton, Dickinson and Company (United States), Olympus Corporation (Japan), Stryker Corporation (United States), Hologic, Inc. (United States), Argon Medical Devices, Inc. (United States), Cook Group Incorporated (United States), Cardinal Health, Inc. (United States), Fujifilm Holdings Corporation (Japan)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.38 Billion
- 2027 Estimated Market Size: USD 1.46 Billion
- Projected Market Size: USD 2.71 Billion by 2036
- Growth Forecast: 7% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Needle Based Biopsy Guns (Product) | Autoimmune Disorder (Application) | Hospitals (End-use)
- Emerging Opportunity Segment: Needle Based Biopsy Guns (Product) | Cancer/tumor (Application) | Ambulatory Surgical Center (End-use)
Market Growth Drivers and Industry Trends
Rising global cancer incidence driving demand for minimally invasive biopsy procedures
The increasing number of cancer diagnoses worldwide is strengthening the need for reliable tissue sampling methods that enable accurate and timely diagnosis. This trend will drive the biopsy needle market growth as minimally invasive biopsy procedures become the preferred approach for obtaining diagnostic specimens while reducing patient discomfort and recovery time. Clinicians across oncology specialties are increasingly utilizing biopsy needles to support early disease detection, tumor characterization, treatment planning, and ongoing monitoring through efficient tissue collection.
Technological advancements improving precision and safety of biopsy needle systems
Continuous improvements in biopsy device engineering are enhancing procedural accuracy while reducing complications associated with tissue sampling. The biopsy needle market benefits from innovations such as improved needle designs, enhanced imaging compatibility, ergonomic handling features, and better tissue acquisition capabilities that support more precise targeting of suspicious lesions. These advancements also contribute to greater physician confidence during image-guided interventions performed across hospitals, diagnostic centers, and ambulatory care settings.
Expanding breast cancer awareness and screening programs boosting diagnostic biopsy adoption
Growing awareness of breast health and broader implementation of screening initiatives are increasing the number of patients undergoing follow-up diagnostic evaluations after abnormal imaging findings. This development will propel the biopsy needle market growth by expanding the use of biopsy procedures for definitive tissue diagnosis before treatment decisions are made. Healthcare providers are integrating minimally invasive biopsy techniques into standardized breast cancer diagnostic pathways to improve diagnostic accuracy while minimizing the need for more invasive surgical procedures.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global cancer incidence driving demand for minimally invasive biopsy procedures | 2.3% | High | North America, Europe | High | Near Term |
| Technological advancements improving precision and safety of biopsy needle systems | 2% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding breast cancer awareness and screening programs boosting diagnostic biopsy adoption | 1.7% | High | Asia Pacific, Europe | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the biopsy needle market, North America held the largest share in 2026, supported by advanced healthcare infrastructure, widespread adoption of minimally invasive diagnostic procedures, and strong demand for accurate tissue sampling. The region benefits from established diagnostic pathways and greater integration of advanced imaging and biopsy technologies, while the growing emphasis on early disease detection continues to support procedural volumes. In addition, favorable reimbursement environments and ongoing investments in hospital and diagnostic capabilities reinforce the region's strong market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to be the fastest-growing region, driven by expanding healthcare infrastructure, improving access to diagnostic services, and increasing awareness of early disease detection. Rising healthcare investment and the modernization of hospitals and diagnostic centers are creating broader opportunities for biopsy procedures across emerging markets. Greater adoption of minimally invasive techniques, together with the growing burden of diseases requiring tissue diagnosis, is expected to strengthen demand for biopsy needles across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Image-Guided ProceduresThe U.S. biopsy needle market is driven by increasing adoption of image-guided minimally invasive procedures across oncology and specialty care. Healthcare providers are prioritizing biopsy devices that improve sampling accuracy while supporting efficient outpatient interventions.
Germany 🇩🇪
Precision Tissue SamplingGermany emphasizes high-quality biopsy needle technologies that support precise tissue collection across diagnostic specialties. Clinical adoption increasingly favors devices designed to improve procedural consistency while integrating with advanced imaging systems.
Japan 🇯🇵
Minimally Invasive PreferenceJapan continues to encourage minimally invasive biopsy procedures as healthcare providers seek improved patient comfort and procedural efficiency. Demand remains focused on biopsy needles that deliver reliable tissue samples across a broad range of clinical applications.
South Korea 🇰🇷
Oncology Diagnostics SupportSouth Korea is expanding the use of biopsy needle technologies alongside growing investments in cancer diagnosis and image-guided interventions. Healthcare facilities are increasingly selecting devices that enhance procedural precision and support streamlined clinical workflows.
France 🇫🇷
Clinical Workflow EfficiencyFrance is strengthening biopsy needle adoption through greater emphasis on efficient diagnostic procedures within hospitals and specialty clinics. The country favors technologies that support consistent tissue acquisition while reducing procedural complexity for clinicians.
Italy 🇮🇹
Diagnostic Procedure EnhancementItaly continues to improve biopsy services by adopting advanced biopsy needle technologies across oncology and pathology practices. Healthcare providers are focusing on devices that facilitate accurate sampling and contribute to more efficient diagnostic pathways.
Segment Leadership and Growth Trends
Biopsy Needle Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Needle Based Biopsy Guns (Largest & Fastest-Growing Segment)
The needle based biopsy guns segment dominated the biopsy needle market, accounting for 73.54% of the market share in 2026, and is expected to remain the fastest-growing product segment throughout the forecast period. Its leadership is driven by the ability to obtain consistent, high-quality tissue samples with enhanced procedural precision and efficiency. These devices improve clinician control, reduce sampling variability, and support minimally invasive diagnostic procedures across multiple clinical applications. Ongoing technological advancements focused on ergonomics, accuracy, and patient comfort are expected to further reinforce the segment's market leadership.
Application Segment Analysis: Autoimmune Disorder (Largest Segment) vs Cancer/tumor (Fastest-Growing Segment)
The autoimmune disorder application segment held the largest share of the market in 2026. Demand is supported by the increasing need for tissue sampling to confirm diagnoses, evaluate disease progression, and guide treatment decisions in complex autoimmune conditions. The growing use of minimally invasive biopsy procedures and greater emphasis on precise pathological assessment continue to strengthen the segment's leading position.
The cancer/tumor application segment is projected to witness the fastest growth over the forecast period. In the biopsy needle market, increasing focus on early cancer diagnosis, expanding adoption of image-guided biopsy procedures, and rising demand for personalized treatment planning are accelerating the use of biopsy needles in oncology. Continuous improvements in diagnostic techniques and growing awareness of early disease detection are expected to support sustained growth.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Center (Fastest-Growing Segment)
Hospitals accounted for the largest end-use share in 2026 owing to their advanced diagnostic infrastructure, availability of specialized healthcare professionals, and capacity to perform a broad range of image-guided and minimally invasive biopsy procedures. Their ability to manage complex patient cases and provide comprehensive pathology services continues to support strong demand for biopsy needle products.
The ambulatory surgical center segment is expected to register the fastest growth during the forecast period. Increasing preference for outpatient diagnostic procedures, reduced hospital stays, and cost-efficient healthcare delivery are encouraging greater adoption of biopsy procedures in these facilities. Continued advancements in minimally invasive techniques and expanding ambulatory care infrastructure are expected to further drive segment growth.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Needle Based Biopsy Guns, Biopsy Needles | Needle Based Biopsy Guns | Needle Based Biopsy Guns |
| Application | Cancer/tumor, Infectious Diseases, Autoimmune Disorder, Others | Autoimmune Disorder | Cancer/tumor |
| End-use | Hospitals, Ambulatory Surgical Center, Others | Hospitals | Ambulatory Surgical Center |
Competitive Landscape and Market Positioning
Key companies in the biopsy needle market:
- Medtronic plc (Ireland)
- Boston Scientific Corporation (United States)
- Becton Dickinson and Company (United States)
- Olympus Corporation (Japan)
- Stryker Corporation (United States)
- Hologic, Inc. (United States)
- Argon Medical Devices, Inc. (United States)
- Cook Group Incorporated (United States)
- Cardinal Health, Inc. (United States)
- Fujifilm Holdings Corporation (Japan)
Clinical precision has become the primary battleground in the biopsy needle market as manufacturers focus on improving tissue acquisition quality while reducing procedural complexity for physicians. Product development increasingly emphasizes enhanced needle control, imaging compatibility, and patient-centered procedural performance, reflecting the growing demand for minimally invasive diagnostics across multiple specialties. Competition also extends beyond device engineering, with suppliers strengthening physician training, procedural guidance, and application-specific portfolios to address varying clinical requirements and healthcare facility preferences without relying on standardized solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Mekon | Jun-26 | Mekon commercialized a new line of semi-automatic and automatic biopsy needle solutions aimed at enhancing precision during minimally invasive tissue sampling. The launch addresses growing clinical demand for automated diagnostic devices and expands the manufacturer's core product portfolio. |
| Limaca Medical Ltd. | Feb-25 | Limaca Medical initiated the U.S. commercial launch of its Precision-GI endoscopic automated motorized EUS biopsy device. This expansion introduces motorized tissue sampling technology to the gastrointestinal biopsy segment, scaling the company's operational footprint in the North American market. |
| Elekta Instrument AB | Apr-24 | Elekta executed a voluntary recall of specific disposable biopsy needles designed for its Leksell Stereotactic System following the detection of microscopic stainless steel debris. Classed by the FDA, the recall highlights manufacturing quality control challenges and temporarily impacts the device supply chain. |
| GE HealthCare | Jun-20 | GE HealthCare secured FDA clearance for contrast-enhanced mammography and biopsy capabilities on its breast imaging platform. The regulatory approval expands the system's diagnostic clinical utility, directly strengthening the company's competitive positioning in advanced, image-guided breast biopsy procedures. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Biopsy Needle Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Biopsy Needle Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of biopsy needle?
How is the biopsy needle industry size expected to evolve during the forecast period?
How are technological advancements strengthening the adoption of biopsy needle systems?
How is expanding cancer screening influencing demand for biopsy procedures?
Why do needle based biopsy guns lead the biopsy needle market?
Which application is expected to grow fastest in the biopsy needle market?
Why does North America lead the biopsy needle market?
What is driving biopsy needle market growth in Asia Pacific?
Which companies dominate the biopsy needle landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization